Riverside Biotech Private Limited
About Riverside Biotech Private Limited
Data last updated:
Riverside Biotech Private Limited is a private limited company based in Sivakasi, Tamil Nadu, India. The company is currently classified as dormant under Section 455 of the Companies Act - it is legally registered but has declared that it is not conducting any business operations. It operates in the horticulture and produce segment of the agriculture sector. It was incorporated on 29 September 2009.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2009PTC073025.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Chockalingam Rajesh Sivamurugan and Rajesh Sreesh.
Its last annual general meeting (AGM) was held on 02 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 340/3 Keelathiruthangal Virudhunagar High Way, Sivakasi, Tamil Nadu, India – 626130.
As per the financials filed for FY 2023, the company reported a revenue of ₹96,000, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹9,510 (net margin 9.9%) and EBITDA of ₹11,310 (EBITDA margin 11.8%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 22% over five years.
Company details
Contact details
Riverside Biotech Private Limited's registered office is in Sivakasi, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address340/3 Keelathiruthangal Virudhunagar High Way, Sivakasi, Tamil Nadu, India – 626130
- IndustryAgriculture, Horticulture & Produce
To see the full contact details of Riverside Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Riverside Biotech is agriculture, forestry, fishing. In detail, this covers production of crops and animals.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A1 | Production of crops and animals |
To see the full business activity and turnover split of Riverside Biotech Private Limited, buy the company report.
Financials of Riverside Biotech Private Limited
FY 2023 filings availableRiverside Biotech Private Limited reported revenue of ₹96,000 (up 7% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 22%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,310 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,510 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | 9.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Riverside Biotech Private Limited, buy the company report.
Board of directors of Riverside Biotech Private Limited
Riverside Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chockalingam Rajesh Sivamurugan | Director | 29 Sep 2009 | 17 Years 0 Months | Current |
| Rajesh Sreesh | Director | 09 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Riverside Biotech Private Limited is audited by SHENABAGAMOORTHY & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHENABAGAMOORTHY & CO | FY 2021 | 009865S |
Shareholding
The shareholding of Riverside Biotech Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Riverside Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Riverside Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riverside Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Riverside Biotech has 1 associated company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Riverside Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Riverside Biotech Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Rajesh Sreesh ceased to be Additional Director on 01 Aug 2023.
Frequently asked questions
Riverside Biotech is classified as "Dormant" under Section 455 of the Companies Act. This means the company is legally registered but has officially declared that it is not currently conducting any business operations. A dormant company can be reactivated by following the prescribed procedures with the Registrar of Companies.
Riverside Biotech is a dormant private limited company based in Sivakasi, Tamil Nadu, India. The company works in horticulture and produce, within the agriculture industry. It was incorporated on 29 September 2009 and is registered under CIN U24232TN2009PTC073025. The company is legally registered but not currently conducting business.
The compliance status of Riverside Biotech is compliant as of 22 July 2026.
Riverside Biotech has 2 current directors:
- Chockalingam Rajesh Sivamurugan - Director
- Rajesh Sreesh - Director
The CIN (Corporate Identification Number) of Riverside Biotech is U24232TN2009PTC073025. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riverside Biotech was incorporated on 29 September 2009. It is registered with the Registrar of Companies, Chennai.
The registered office of Riverside Biotech is at 3403 Keelathiruthangal Virudhunagar High Way, Sivakasi, Tamil Nadu, India – 626130.
The latest financial statements of Riverside Biotech on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 02 August 2023. Year-wise statements from 2015 are in the company report.
Riverside Biotech operates in the agriculture industry, in the horticulture and produce segment.
Rajesh Sreesh ceased to be Additional Director on 01 Aug 2023. Rajesh Sreesh was appointed as Director on 09 Mar 2022. Ramasamy Chockalingam ceased to be Director on 09 Mar 2022. Riverside Biotech has 4 board changes on record in total.